EFSA Releases Scientific Assessment of GM Maize MZIR 098July 1, 2020
The European Food Safety Authority (EFSA) Panel on Genetically Modified Organisms (GMO Panel) has published the Scientific Opinion which reports on the outcome of its risk assessment of maize MZIR098 according to the scope as defined in the application EFSA‐GMO‐DE‐2017‐142. The Scientific Opinion is published based on the application from the Competent Authority of Germany for authorization of maize MZIR098 (Unique Identifier SYN‐ØØØ98‐3), submitted by Syngenta Crop Protection N.V./S.A. according to Regulation (EC) No 1829/20031.
The scope of application EFSA‐GMO‐DE‐2017‐142 is for food and feed uses, import and processing of GM herbicide tolerant and insect resistant maize MZIR098 in the European Union (EU). According to the Scientific Opinion, the molecular characterization data and bioinformatic analyses do not identify issues requiring food/feed safety assessment. None of the identified differences in the agronomic/phenotypic and compositional characteristics tested between maize MZIR 098 and its conventional counterpart needs further assessment, except for neutral detergent fiber (NDF) in grains, which does not raise nutritional and safety concerns. The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the eCry3.1Ab, mCry3A, and PAT proteins as expressed in maize MZIR 098, and finds no evidence that the genetic modification would change the overall allergenicity of maize MZIR 098. In the context of this application, the consumption of food and feed from maize MZIR 098 does not represent a nutritional concern in humans and animals.
The GMO Panel concludes that maize MZIR 098 is as safe as its conventional counterpart and the non‐GM maize reference varieties tested.
For more details, read the scientific opinion in the EFSA Journal.
You might also like:
- Maize MZIR098 in ISAAA GM Approval Database
- EFSA Releases Scientific Opinion on Five-Event Stack GM Maize
- EFSA Releases Scientific Opinion on Six-Event GM Maize
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Webinar: Bio-entrepreneurship Opportunities in Genome Editing
- African Women for Biosciences Embrace Social Media for Communicating Science
- Study of 100 Varieties Reveals Tomato's Hidden Mutations
- 15 Canadian Universities Sign Charter to Address Climate Change
- Scientists Complete Field Trial of Swedish Transgenic Trees
- EFSA Releases Scientific Assessment of GM Maize MZIR 098
- Plant Gene to Boost Phosphorous Intake
- GM Rice Provides Natural Source of Antihypertensive Agents
Plant Breeding Innovations
- Gene Editing Leads to High Yield and Enhanced Aroma in Rice
- Computational Biology Experts Expand Genome Editing Applications
Read the latest:
- Crop Biotech Update (August 3, 2022)
- Genome Editing Supplement (July 20, 2022)
- Gene Drive Supplement (July 27, 2022)
Subscribe to CBU: